| 常用名 | Remogliflozin etabonate | CAS号 | 442201-24-3 |
|---|---|---|---|
| 价格 | $需询单/100g $需询单/1kg $需询单/100kg $需询单/1000kg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: Remogliflozin etabonate (GSK189075) is an orally active, selective and low-affinity sodium glucose cotransporter (SGLT2) inhibitor with Ki values of 1.95 μM, 2.14 μM, 43.1 μM, 8.57 μM for hSGLT2, rSGLT2, hSGLT1, rSGLT1, respectively. Remogliflozin etabonate is a prodrug based on benzylpyrazole glucoside and is metabolized to its active form, Remogliflozin, in the body. Remogliflozin etabonate exhibits antidiabetic efficacy in rodent models[1]. 物理化学性质: CAS号:442201-24-3 常用中文名:Remogliflozin etabonate 常用英文名:Remogliflozin etabonate 分子式:C26H38N2O9 分子量:522.58800 密度:N/A 沸点:N/A 熔点:N/A 闪点:N/A 储存条件:2-8°C |